Cardiotoxicity evaluation using human embryonic stem cells and induced pluripotent stem cell-derived cardiomyocytes

被引：24
|
作者：
Zhao, Qi [1 ]
Wang, Xijie [1 ]
Wang, Shuyan [1 ]
Song, Zheng [1 ]
Wang, Jiaxian [2 ]
Ma, Jing [1 ]
机构：
[1] Natl Shanghai Ctr New Drug Safety Evaluat & Res, China State Inst Pharmaceut Ind, Shanghai, Peoples R China
[2] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China
来源：
STEM CELL RESEARCH & THERAPY | 2017年 / 8卷
关键词：
Stem cells; Cardiomyocytes; Cardiotoxicity; Pharmacology; DE-POINTES; LONG-QT; HALOPERIDOL; PROLONGATION; MAGNESIUM; ARRAYS; MODEL;
D O I：
10.1186/s13287-017-0473-x
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Background: Cardiotoxicity remains an important concern in drug discovery. Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) have become an attractive platform to evaluate cardiotoxicity. However, the consistency between human embryonic stem cell-derived cardiomyocytes (hESC-CMs) and human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) in prediction of cardiotoxicity has yet to be elucidated. Methods: Here we screened the toxicities of four representative drugs (E-4031, isoprenaline, quinidine, and haloperidol) using both hESC-CMs and hiPSC-CMs, combined with an impedance-based bioanalytical method. Results: It showed that both hESC-CMs and hiPSC-CMs can recapitulate cardiotoxicity and identify the effects of well-characterized compounds. Conclusions: The combined platform of hPSC-CMs and an impedance-based bioanalytical method could improve preclinical cardiotoxicity screening, holding great potential for increasing drug development accuracy.
引用
收藏
页数：7
相关论文
共 50 条
  • [41] Cyclophosphamide arrhythmogenicitytesting using human-induced pluripotent stem cell-derived cardiomyocytes
    A. D. Podgurskaya
    M. M. Slotvitsky
    V. A. Tsvelaya
    S. R. Frolova
    S. G. Romanova
    V. A. Balashov
    K. I. Agladze
    Scientific Reports, 11
  • [42] Proarrhythmia risk prediction using human induced pluripotent stem cell-derived cardiomyocytes
    Yamazaki, Daiju
    Kitaguchi, Takashi
    Ishimura, Masakazu
    Taniguchi, Tomohiko
    Yamanishi, Atsuhiro
    Saji, Daisuke
    Takahashi, Etsushi
    Oguchi, Masao
    Moriyama, Yuta
    Maeda, Sanae
    Miyamoto, Kaori
    Morimura, Kaoru
    Ohnaka, Hiroki
    Tashibu, Hiroyuki
    Sekino, Yuko
    Miyamoto, Norimasa
    Kanda, Yasunari
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2018, 136 (04) : 249 - 256
  • [43] In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes
    Tanaka, Tomofumi
    Tohyama, Shugo
    Murata, Mitsushige
    Nomura, Fumimasa
    Kaneko, Tomoyuki
    Chen, Hao
    Hattori, Fumiyuki
    Egashira, Toru
    Seki, Tomohisa
    Ohno, Yohei
    Koshimizu, Uichi
    Yuasa, Shinsuke
    Ogawa, Satoshi
    Yamanaka, Shinya
    Yasuda, Kenji
    Fukuda, Keiichi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 385 (04) : 497 - 502
  • [44] Cyclophosphamide arrhythmogenicitytesting using human-induced pluripotent stem cell-derived cardiomyocytes
    Podgurskaya, A. D.
    Slotvitsky, M. M.
    Tsvelaya, V. A.
    Frolova, S. R.
    Romanova, S. G.
    Balashov, V. A.
    Agladze, K. I.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [45] Small Molecules Inducing Robust Proliferation of Embryonic Stem Cell or Induced Pluripotent Stem Cell-derived Cardiomyocytes
    Uosaki, Hideki
    Fujiwara, Masataka
    Yamashita, Jun K.
    CIRCULATION, 2010, 122 (21)
  • [46] The electrocardiogram of human embryonic stem cell-derived cardiomyocytes
    Reppel, M
    Pillekamp, F
    Brockmeier, K
    Matzkies, M
    Bekcioglu, A
    Lipke, T
    Nguemo, F
    Bonnemeier, H
    Hescheler, J
    JOURNAL OF ELECTROCARDIOLOGY, 2005, 38 (04) : 166 - 170
  • [47] AFTERDEPOLARIZATIONS OCCUR IN CARDIOMYOCYTES DERIVED FROM HUMAN EMBRYONIC STEM CELLS AND INDUCED PLURIPOTENT STEM CELLS
    Gantz, J. A.
    Laflamme, M.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (01) : 108 - 108
  • [48] Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Soluble Factors from Human Mesenchymal Stem Cells
    Yoshida, Shohei
    Miyagawa, Shigeru
    Fukushima, Satsuki
    Kawamura, Takuji
    Kashiyama, Noriyuki
    Ohashi, Fumiya
    Toyofuku, Toshihiko
    Toda, Koichi
    Sawa, Yoshiki
    MOLECULAR THERAPY, 2018, 26 (11) : 2681 - 2695
  • [49] An in vitro assessment of delayed HDAC inhibitor-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes
    Kopljar, Ivan
    Vlaminckx, Eddy
    Lu, Hua Rong
    Gallacher, David
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2016, 81 : 385 - 385
  • [50] Automated image analysis system for studying cardiotoxicity in human pluripotent stem cell-Derived cardiomyocytes
    Lu Cao
    Andries D. van der Meer
    Fons J. Verbeek
    Robert Passier
    BMC Bioinformatics, 21
12345